3D diffusion-weighted whole-body MR shows metastatic disease

Article

Developed by radiologist Dr. Taro Takahara and colleagues at Tokai University School of Medicine in Japan, diffusion-weighted whole-body MR imaging with background body signal suppression (DWIBS) paves the way for practical whole-body 3D MR diffusion imaging. A new STIR-EPI sequence, performed with SENSE parallel processing, permits long acquisition times during free breathing to boost contrast resolution and overcome fat saturation problems.

Developed by radiologist Dr. Taro Takahara and colleagues at Tokai University School of Medicine in Japan, diffusion-weighted whole-body MR imaging with background body signal suppression (DWIBS) paves the way for practical whole-body 3D MR diffusion imaging. A new STIR-EPI sequence, performed with SENSE parallel processing, permits long acquisition times during free breathing to boost contrast resolution and overcome fat saturation problems.

Gray scale was reversed, black for white, producing a rotating 3D maximum intensity projection that resembled volumetric displays now generated with FDG-PET. The mechanism for producing DWI contrast in metastatic disease is not clearly understood but is thought to be associated with large cell sizes and high cellular densities that are common in cancerous tissue. Takahara described the approach at the International Society for Magnetic Resonance in Medicine meeting.

Recent Videos
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Related Content
© 2025 MJH Life Sciences

All rights reserved.